The iconic rise of Viagra has consistently remained a example of pharmaceutical success, however its position within the broader industry now triggers questions about long-term gains. Copycat versions are undercutting patent protection , prompting anxieties that supporting companies significantly dependent to Viagra's former position could be a spe